|
Welcome,
Guest
|
Profile for Any Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Associated with Reldesemtiv Within Individuals With ALS. (raftcongo48)
|
Signature
|
|
Welcome,
Guest
|
|
Signature
|